Direct-Acting Antivirals in the Treatment of Hepatitis C Virus Recurrence after Liver Transplantation: Real-life Experience in a Mexican Cohort

Hepatitis C virus (HCV) infection is one of the most frequent causes of liver transplantation (LT) worldwide. Patients with HCV viremia at the time of LT universally develop recurrent HCV in the allograft, leading to accelerated fibrosis and graft loss. Treatment with direct-acting antivirals (DAA)...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Archives of medical research Ročník 52; číslo 7; s. 713 - 718
Hlavní autori:	Kauffman-Ortega, Eric, Ruiz-Manriquez, Jesus, Olivas-Martinez, Antonio, Campos-Murguía, Alejandro, Flores-García, Nayelli C, Márquez-Guillén, Ernesto, López-Yáñez, Silvia, Sánchez-Ávila, Francisco, Toapanta-Yanchapaxi, Liz, Paez-Zayas, Victor M, García-Juárez, Ignacio
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 01.10.2021
Predmet:	Antiviral Agents - therapeutic use Cohort Studies Direct-acting antivirals Hepacivirus - genetics Hepatitis C - drug therapy Hepatitis C virus Hepatitis C, Chronic - drug therapy Humans Liver transplant Liver Transplantation Recurrence Retrospective Studies Treatment Outcome Liver transplant Hepatitis C virus Direct-acting antivirals
ISSN:	0188-4409, 1873-5487, 1873-5487
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!